HBB

Hemoglobin subunit beta (HBB) is a gene that encodes one of the two types of subunits of hemoglobin, the protein responsible for transporting oxygen in the blood. Hemoglobin is made up of four protein subunits; typically, two alpha (α) globin and two beta (β) globin subunits. The HBB gene provides instructions for making the beta globin subunit. Variations in the HBB gene are associated with several blood disorders, including sickle cell anemia, beta-thalassemia, and beta-hemoglobinopathies.

Structure

The HBB gene is located on the short (p) arm of chromosome 11 at position 15.5, more precisely at 11p15.5. The gene spans approximately 1.6 kilobases and consists of three exons and two introns. The encoded beta globin protein is composed of 146 amino acids and is a vital component of adult hemoglobin (HbA), which has a quaternary structure of two alpha and two beta chains.

Function

Beta globin is a crucial component of hemoglobin, the protein in red blood cells that carries oxygen from the lungs to the rest of the body and returns carbon dioxide from the body to the lungs to be exhaled. Hemoglobin's ability to carry oxygen depends on its complete structure, including the presence of both alpha and beta globin subunits. The proper function of the HBB gene is essential for the effective transport of oxygen and carbon dioxide, which is critical for cellular respiration and energy production in the body.

Genetic Disorders

Alterations or mutations in the HBB gene can lead to several types of blood disorders, which vary in severity and manifestation:

Sickle Cell Anemia

Sickle cell anemia is caused by a specific mutation in the HBB gene, which results in the production of an abnormal version of beta globin known as hemoglobin S (HbS). When oxygen levels are low, HbS can cause red blood cells to become rigid and shaped like a sickle, leading to blockages in blood vessels, pain, infections, and organ damage.

Beta-Thalassemia

Beta-thalassemia is a group of inherited blood disorders characterized by reduced or absent production of beta globin. This leads to a lack of functional hemoglobin, resulting in anemia, which is a deficiency of red blood cells or hemoglobin in the blood. The severity of beta-thalassemia depends on the nature of the mutation in the HBB gene.

Beta-Hemoglobinopathies

Beta-hemoglobinopathies are a group of disorders caused by mutations in the HBB gene that affect the structure, function, or production of beta globin. These disorders include sickle cell anemia and various forms of beta-thalassemia.

Diagnosis and Treatment

Diagnosis of disorders related to the HBB gene typically involves blood tests to evaluate hemoglobin levels and identify abnormal forms of hemoglobin. Genetic testing can confirm the presence of mutations in the HBB gene. Treatment options vary depending on the disorder and its severity but may include blood transfusions, medication to reduce symptoms or complications, and in some cases, bone marrow or stem cell transplantation.

Research Directions

Research on the HBB gene and its associated disorders continues to advance, with efforts focused on better understanding the genetic mechanisms underlying these conditions and developing more effective treatments. Gene therapy, which involves inserting a normal copy of the HBB gene into the patient's cells, is one area of active research that holds promise for curing or significantly improving outcomes for individuals with disorders caused by mutations in the HBB gene.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian